WallStreetZenWallStreetZen

NASDAQ: NOTV
Inotiv Inc Stock

$4.42+0.10 (+2.31%)
Updated Apr 22, 2024
NOTV Price
$4.42
Fair Value Price
N/A
Market Cap
$113.99M
52 Week Low
$1.61
52 Week High
$11.42
P/E
-3.4x
P/B
0.45x
P/S
0.16x
PEG
N/A
Dividend Yield
N/A
Revenue
$585.17M
Earnings
-$33.21M
Gross Margin
30.3%
Operating Margin
0.66%
Profit Margin
-5.7%
Debt to Equity
2.29
Operating Cash Flow
$29M
Beta
1.11
Next Earnings
May 9, 2024
Ex-Dividend
N/A
Next Dividend
N/A

NOTV Overview

Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment provides analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to identify and measure drug and metabolite concentrations in complex biological matrices; in vivo sampling services for the continuous monitoring of chemical changes in life; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; non-clinical toxicology and pathology services; and climate-controlled archiving services for its customers' data and samples. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories, including disposables, training, and systems qualification; physiology monitoring tools; liquid chromatography and electrochemistry instruments platforms; analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; and in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It has an agreement with BioVaxys to conduct preclinical toxicity studies for its Covid-T Immunodiagnostic program. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NOTV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NOTV is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NOTV is good value based on its book value relative to its share price (0.45x), compared to the US Diagnostics & Research industry average (4.05x)
P/B vs Industry Valuation
NOTV is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more NOTV due diligence checks available for Premium users.

Be the first to know about important NOTV news, forecast changes, insider trades & much more!

NOTV News

Valuation

NOTV fair value

Fair Value of NOTV stock based on Discounted Cash Flow (DCF)
Price
$4.42
Fair Value
$4.41
Overvalued by
0.28%
NOTV is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

NOTV price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-3.4x
Industry
36.48x
Market
41x

NOTV price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.45x
Industry
4.05x
NOTV is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NOTV's financial health

Profit margin

Revenue
$135.5M
Net Income
-$15.4M
Profit Margin
-11.4%
NOTV's Earnings (EBIT) of $3.87M... subscribe to Premium to read more.
Interest Coverage Financials
NOTV's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$835.5M
Liabilities
$581.3M
Debt to equity
2.29
NOTV's short-term assets ($190.69M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NOTV's long-term liabilities ($471.86M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NOTV's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
NOTV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$6.5M
Investing
-$4.0M
Financing
-$2.9M
NOTV's operating cash flow ($28.75M)... subscribe to Premium to read more.
Debt Coverage Financials

NOTV vs Diagnostic & Research Stocks

TickerMarket Cap1d %P/EP/B
NOTV$113.99M+2.31%-3.40x0.45x
STIM$111.29M-1.58%-3.56x3.25x
FONR$108.72M-3.63%8.57x0.66x
BDSX$125.06M+3.20%-2.02x27.30x
PRPH$88.42M-6.84%-5.00x1.79x

Inotiv Stock FAQ

What is Inotiv's quote symbol?

(NASDAQ: NOTV) Inotiv trades on the NASDAQ under the ticker symbol NOTV. Inotiv stock quotes can also be displayed as NASDAQ: NOTV.

If you're new to stock investing, here's how to buy Inotiv stock.

What is the 52 week high and low for Inotiv (NASDAQ: NOTV)?

(NASDAQ: NOTV) Inotiv's 52-week high was $11.42, and its 52-week low was $1.61. It is currently -61.29% from its 52-week high and 174.53% from its 52-week low.

How much is Inotiv stock worth today?

(NASDAQ: NOTV) Inotiv currently has 25,790,680 outstanding shares. With Inotiv stock trading at $4.42 per share, the total value of Inotiv stock (market capitalization) is $113.99M.

Inotiv stock was originally listed at a price of $7.63 in Dec 31, 1997. If you had invested in Inotiv stock at $7.63, your return over the last 26 years would have been -42.03%, for an annualized return of -2.08% (not including any dividends or dividend reinvestments).

How much is Inotiv's stock price per share?

(NASDAQ: NOTV) Inotiv stock price per share is $4.42 today (as of Apr 22, 2024).

What is Inotiv's Market Cap?

(NASDAQ: NOTV) Inotiv's market cap is $113.99M, as of Apr 23, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Inotiv's market cap is calculated by multiplying NOTV's current stock price of $4.42 by NOTV's total outstanding shares of 25,790,680.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.